Cancer statistics, 2012, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, pp.10-29, 2012. ,
DOI : 10.3322/caac.20138
Update on current care guidelines: ovarian cancer, pp.1300-1301, 2012. ,
Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group Study, Gynecologic Oncology, vol.127, issue.3, pp.495-501 ,
DOI : 10.1016/j.ygyno.2012.09.002
Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT, Journal of Clinical Oncology, vol.25, issue.27, pp.4187-4193, 2007. ,
DOI : 10.1200/JCO.2006.09.7527
Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group, Journal of Clinical Oncology, vol.21, issue.2, pp.283-290, 2003. ,
DOI : 10.1200/JCO.2003.10.104
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube, Gynecologic Oncology, vol.125, issue.3, pp.640-645, 2012. ,
DOI : 10.1016/j.ygyno.2012.02.034
Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer, Journal of Clinical Oncology, vol.30, issue.31, pp.3841-3847, 2012. ,
DOI : 10.1200/JCO.2011.38.8082
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer, New England Journal of Medicine, vol.365, issue.26, pp.2473-2483, 2011. ,
DOI : 10.1056/NEJMoa1104390
A Phase 3 Trial of Bevacizumab in Ovarian Cancer, New England Journal of Medicine, vol.365, issue.26, pp.2484-2496, 2011. ,
DOI : 10.1056/NEJMoa1103799
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer, New England Journal of Medicine, vol.366, issue.15, pp.1382-1392, 2012. ,
DOI : 10.1056/NEJMoa1105535
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer, Cochrane Database Syst Rev, vol.11, p.5340, 2011. ,
Treatment guidelines in ovarian cancer, Clinical and Translational Oncology, vol.170, issue.[Suppl1], pp.308-316, 2007. ,
DOI : 10.1007/s12094-007-0058-8
Secondary cytoreductive surgery for ovarian cancer, Obstet Gynecol Clin North Am, vol.21, pp.167-178, 1994. ,
Genomic tests for ovarian cancer detection and management, Evid Rep Technol Assess, vol.145, pp.1-100, 2006. ,
Genomic analysis of epithelial ovarian cancer, Cell Research, vol.62, issue.5, pp.538-548, 2008. ,
DOI : 10.1186/1476-4598-3-27
Copy Number Variation Analysis of Matched Ovarian Primary Tumors and Peritoneal Metastasis, PLoS ONE, vol.222, issue.12, p.28561, 2011. ,
DOI : 10.1371/journal.pone.0028561.s007
Microenvironmental regulation of metastasis, Nature Reviews Cancer, vol.19, issue.4, pp.239-252, 2009. ,
DOI : 10.1038/nrc2618
Tumor???stromal cell interactions and opportunities for therapeutic intervention, Current Opinion in Pharmacology, vol.10, issue.4, pp.369-374, 2010. ,
DOI : 10.1016/j.coph.2010.06.010
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT, Annual Review of Pathology: Mechanisms of Disease, vol.1, issue.1, pp.119-150, 2006. ,
DOI : 10.1146/annurev.pathol.1.110304.100224
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells, Proceedings of the National Academy of Sciences, vol.106, issue.10, pp.3806-3811, 2009. ,
DOI : 10.1073/pnas.0900244106
Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression, PLoS ONE, vol.72, issue.4, p.4992, 2009. ,
DOI : 10.1371/journal.pone.0004992.s004
Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses, International Journal of Cancer, vol.13, pp.2143-2152, 2010. ,
DOI : 10.1002/ijc.24881
Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis, International Journal of Cancer, vol.16, pp.2090-2101, 2010. ,
DOI : 10.1002/ijc.24886
Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12, International Journal of Cancer, vol.2010, issue.3, pp.715-725, 2011. ,
DOI : 10.1002/ijc.25619
Interactions between endothelial selectins and cancer cells regulate metastasis, Frontiers in Bioscience, vol.16, issue.1, pp.3233-3251, 2012. ,
DOI : 10.2741/3909
Role of the Endothelium during Tumor Cell Metastasis: Is the Endothelium a Barrier or a Promoter for Cell Invasion and Metastasis?, Journal of Biophysics, vol.53, issue.5, p.183516, 2008. ,
DOI : 10.1158/0008-5472.CAN-05-0821
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression, Cancer and Metastasis Reviews, vol.9, issue.5, pp.195-208, 2012. ,
DOI : 10.1007/s10555-011-9340-x
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, vol.174, issue.7069, pp.820-827, 2005. ,
DOI : 10.1038/nature04186
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
DOI : 10.1016/j.cell.2011.02.013
Interleukin-1?? Promotes Ovarian Tumorigenesis through a p53/NF-??B-Mediated Inflammatory Response in Stromal Fibroblasts, Neoplasia, vol.15, issue.4, pp.409-420, 2013. ,
DOI : 10.1593/neo.121228
Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties, PLoS ONE, vol.474, issue.5, p.38340, 2012. ,
DOI : 10.1371/journal.pone.0038340.s002
Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model, Journal of Translational Medicine, vol.11, issue.1, p.28, 2013. ,
DOI : 10.1158/0008-5472.CAN-10-0538
URL : https://hal.archives-ouvertes.fr/inserm-00794947
Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids, Cancer Cell, vol.20, issue.3, pp.370-383, 2011. ,
DOI : 10.1016/j.ccr.2011.08.010
Mesenchymal stem cells, Journal of Orthopaedic Research, vol.86, issue.5, pp.641-650, 1991. ,
DOI : 10.1002/jor.1100090504
Transplantation of Marrow to Extramedullary Sites, Science, vol.161, issue.3836, pp.54-56, 1968. ,
DOI : 10.1126/science.161.3836.54
Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method, Exp Hematol, vol.2, pp.83-92, 1974. ,
Osteogenic stem cells in the bone marrow, Bone and Mineral Research, pp.243-272, 1990. ,
DOI : 10.1016/B978-0-444-81371-8.50012-1
MSC Frequency Correlates with Blood Vessel Density in Equine Adipose Tissue, Tissue Engineering Part A, vol.15, issue.2, pp.221-229, 2009. ,
DOI : 10.1089/ten.tea.2008.0103
Mesenchymal Stromal Cells, Annals of the New York Academy of Sciences, vol.22, issue.1, pp.101-117, 2009. ,
DOI : 10.1111/j.1749-6632.2009.04607.x
Comprehensive Characterization of Mesenchymal Stem Cells from Human Placenta and Fetal Membrane and Their Response to Osteoactivin Stimulation, Stem Cells International, vol.238, issue.5, p.658356, 2012. ,
DOI : 10.1006/bbrc.1995.1712
In Search of the In Vivo Identity of Mesenchymal Stem Cells, Stem Cells, vol.21, issue.9, pp.2287-2299, 2008. ,
DOI : 10.1634/stemcells.2007-1122
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs, Cell Stem Cell, vol.3, issue.3, pp.301-313, 2008. ,
DOI : 10.1016/j.stem.2008.07.003
Differential expression of ?-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells, Journal of Neuroscience Research, vol.103, issue.4, pp.430-435, 1994. ,
DOI : 10.1002/jnr.490390410
Endothelial/Pericyte Interactions, Circulation Research, vol.97, issue.6, pp.512-523, 2005. ,
DOI : 10.1161/01.RES.0000182903.16652.d7
Role of pericytes in vascular morphogenesis, EXS, vol.94, pp.115-125, 2005. ,
DOI : 10.1007/3-7643-7311-3_8
Mesenchymal Stem Cells: Revisiting History, Concepts, and Assays, Cell Stem Cell, vol.2, issue.4, pp.313-319, 2008. ,
DOI : 10.1016/j.stem.2008.03.002
URL : http://doi.org/10.1016/j.stem.2008.03.002
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues, Science, vol.276, issue.5309, pp.71-74, 1997. ,
DOI : 10.1126/science.276.5309.71
The mesengenic process, Clin Plast Surg, vol.21, pp.429-435, 1994. ,
Multilineage Potential of Adult Human Mesenchymal Stem Cells, Science, vol.284, issue.5411, pp.143-147, 1999. ,
DOI : 10.1126/science.284.5411.143
Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms, Circulation Research, vol.94, issue.5, pp.678-685, 2004. ,
DOI : 10.1161/01.RES.0000118601.37875.AC
Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment, Biochemical and Biophysical Research Communications, vol.354, issue.3, pp.700-706, 2007. ,
DOI : 10.1016/j.bbrc.2007.01.045
Human Mesenchymal Stem Cells Efficiently Manage Oxidative Stress, Stem Cells and Development, vol.19, issue.12, pp.1885-1893, 2010. ,
DOI : 10.1089/scd.2010.0093
In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein, Nature Medicine, vol.9, issue.11, pp.1428-1432, 2003. ,
DOI : 10.1038/nm951
Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells, Nature Medicine, vol.340, issue.2, pp.240-245, 2006. ,
DOI : 10.1038/nm1342
Wnt proteins are lipid-modified and can act as stem cell growth factors, Nature, vol.367, issue.6938, pp.448-452, 2003. ,
DOI : 10.1084/jem.192.12.1707
Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells, Cell Stem Cell, vol.6, issue.3, pp.251-264, 2010. ,
DOI : 10.1016/j.stem.2010.02.001
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche, Cell, vol.118, issue.2, pp.149-161, 2004. ,
DOI : 10.1016/j.cell.2004.07.004
Osteoblastic cells regulate the haematopoietic stem cell niche, Osteoblastic cells regulate the haematopoietic stem cell niche, pp.841-846, 2003. ,
DOI : 10.1038/nature02040
Identification of the haematopoietic stem cell niche and control of the niche size, Nature, vol.425, issue.6960, pp.836-841, 2003. ,
DOI : 10.1038/nature02041
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells, Nature Medicine, vol.36, issue.6, pp.657-664, 2006. ,
DOI : 10.1038/nm1417
Frontiers of Immunological Tolerance, Methods Mol Biol, vol.380, pp.1-24, 2007. ,
DOI : 10.1007/978-1-59745-395-0_1
Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation, Clinical and Developmental Immunology, vol.9, issue.8, p.854846, 2012. ,
DOI : 10.3324/haematol.11240
Immunomodulation by mesenchymal stem cells and clinical experience, Journal of Internal Medicine, vol.24, issue.5, pp.509-525, 2007. ,
DOI : 10.1097/01.TP.0000048488.35010.95
Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells, Stem Cells and Development, vol.21, issue.14, pp.2724-2752, 2012. ,
DOI : 10.1089/scd.2011.0722
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents, JNCI Journal of the National Cancer Institute, vol.96, issue.21, pp.1593-1603, 2004. ,
DOI : 10.1093/jnci/djh299
Tumor Irradiation Increases the Recruitment of Circulating Mesenchymal Stem Cells into the Tumor Microenvironment, Cancer Research, vol.67, issue.24, pp.11687-11695, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-1406
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.9, issue.7162, pp.557-563, 2007. ,
DOI : 10.1038/nature06188
Tumors: Wounds That Do Not Heal--Redux, Cancer Immunology Research, vol.3, issue.1, pp.1650-1659, 1986. ,
DOI : 10.1158/2326-6066.CIR-14-0209
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288010
Inflammation and cancer: back to Virchow? Lancet, pp.539-545, 2001. ,
DOI : 10.1016/s0140-6736(00)04046-0
Chemokines in cancer, Cytokine & Growth Factor Reviews, vol.13, issue.2, pp.143-154, 2002. ,
DOI : 10.1016/S1359-6101(01)00033-8
Breast tumor microenvironment: In the eye of the cytokine storm, Cell Cycle, vol.10, issue.15, pp.2420-2421, 2011. ,
DOI : 10.4161/cc.10.15.16204
URL : https://hal.archives-ouvertes.fr/hal-01431948
Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma, Cancer Res, vol.59, pp.4681-4687, 1999. ,
CXC chemokines in angiogenesis, J Leukoc Biol, vol.68, pp.1-8, 2000. ,
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms, The Journal of Immunology, vol.165, issue.4, pp.1992-2000, 2000. ,
DOI : 10.4049/jimmunol.165.4.1992
Involvement of chemokine receptors in breast cancer metastasis, Nature, vol.410, issue.6824, pp.50-56, 2001. ,
DOI : 10.1038/35065016
Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma, Cancer Res, vol.62, pp.2937-2941, 2002. ,
Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis, Journal of Translational Medicine, vol.10, issue.1, p.121, 2012. ,
DOI : 10.1097/JTO.0b013e3181b44321
Migratory neighbors and distant invaders: tumor-associated niche cells, Genes & Development, vol.22, issue.5, pp.559-574, 2008. ,
DOI : 10.1101/gad.1636908
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731657
Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors, Journal of Clinical Investigation, vol.112, issue.8, pp.1142-1151, 2003. ,
DOI : 10.1172/JCI200318549
Human ovarian carcinoma???associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production, Journal of Clinical Investigation, vol.121, issue.8, pp.3206-3219, 2011. ,
DOI : 10.1172/JCI45273DS1
Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses, Stem Cells, vol.25, issue.1, pp.99-107, 2008. ,
DOI : 10.1634/stemcells.2007-0563
The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells, Cell Communication and Signaling, vol.11, issue.1, p.31, 2013. ,
DOI : 10.2353/ajpath.2009.090028
Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells, Stem Cells, vol.25, issue.Pt 3, pp.789-797, 2008. ,
DOI : 10.1634/stemcells.2007-0742
Bone Marrow Contribution to Tumor-Associated Myofibroblasts and Fibroblasts, Cancer Research, vol.64, issue.23, pp.8492-8495, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-1708
Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts, Gynecologic Oncology, vol.123, issue.2, pp.379-386, 2011. ,
DOI : 10.1016/j.ygyno.2011.08.005
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts, Journal of Clinical Investigation, vol.122, issue.10, pp.3603-3617, 2012. ,
DOI : 10.1172/JCI62229DS1
Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles, International Journal of Hematology, vol.86, issue.1, pp.8-16, 2007. ,
DOI : 10.1532/IJH97.06230
TGF-?? Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment, Cancer Research, vol.73, issue.16, pp.5016-5028, 2013. ,
DOI : 10.1158/0008-5472.CAN-13-0023
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nature Medicine, vol.7, issue.12, pp.1339-1346, 2001. ,
DOI : 10.1038/nm1201-1339
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer, Cancer Res, vol.62, pp.5930-5938, 2002. ,
Stromal cell-derived factor-1?? (SDF-1??/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation, Experimental Cell Research, vol.308, issue.2, pp.241-253, 2005. ,
DOI : 10.1016/j.yexcr.2005.04.024
Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1?? (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway-Dependent NF-??B Activation, Cancer Research, vol.65, issue.21, pp.9891-9898, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-1293
Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells, Mol Cancer Res, vol.3, pp.227-236, 2005. ,
and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res, vol.65, pp.12465-472, 2005. ,
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion, Cell, vol.121, issue.3, pp.335-348, 2005. ,
DOI : 10.1016/j.cell.2005.02.034
Cancer Stem Cells: Models and Concepts, Annual Review of Medicine, vol.58, issue.1, pp.267-284, 2007. ,
DOI : 10.1146/annurev.med.58.062105.204854
Cancer Stem Cells--Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells, Cancer stem cells?perspectives on current status and future directions: AACR Workshop on cancer stem cells, pp.9339-9344, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-3126
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors, Cancer Research, vol.68, issue.11, pp.4311-4320, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0364
Cancer stem cell definitions and terminology: the devil is in the details, Nature Reviews Cancer, vol.2, issue.11, pp.767-775, 2012. ,
DOI : 10.1038/nrc3368
Prospective identification of tumorigenic breast cancer cells, Proceedings of the National Academy of Sciences, vol.100, issue.7, pp.3983-3988, 2003. ,
DOI : 10.1073/pnas.0530291100
Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks, Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, pp.614-624, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-0538
URL : https://hal.archives-ouvertes.fr/hal-01431944
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts, Journal of Clinical Investigation, vol.120, issue.2, pp.1485-497, 2010. ,
DOI : 10.1172/JCI39397DS1
URL : https://hal.archives-ouvertes.fr/hal-01431952
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, vol.453, issue.7302, pp.133-137, 2010. ,
DOI : 10.1038/nature09161
Phenotypic characterization of human colorectal cancer stem cells, Proceedings of the National Academy of Sciences, vol.104, issue.24, pp.10158-10163, 2007. ,
DOI : 10.1073/pnas.0703478104
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells, Cancer Research, vol.65, issue.23, pp.10946-10951, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-2018
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer, Cancer Res, vol.65, pp.3025-3029, 2005. ,
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach, Journal of Experimental & Clinical Cancer Research, vol.32, issue.1, p.48, 2013. ,
DOI : 10.1186/1756-9966-32-48
Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells, Journal of Cancer, vol.5, issue.5, pp.301-310, 2014. ,
DOI : 10.7150/jca.8610
Cancer Stem Cells and Aneuploid Populations within Developing Tumors Are the Major Determinants of Tumor Dormancy, Cancer Research, vol.69, issue.24, pp.9245-9253, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-2802
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival, Cancer Research, vol.71, issue.11, pp.3991-4001, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-3175
URL : https://hal.archives-ouvertes.fr/hal-01431946
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells, International Journal of Cancer, vol.120, issue.Suppl 1, pp.29-39, 2012. ,
DOI : 10.1002/ijc.25967
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden, Molecular Cancer, vol.12, issue.1, p.24, 2013. ,
DOI : 10.1016/j.stem.2010.12.007
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/??-catenin???ATP-binding cassette G2 signaling, Oncogene, vol.155, issue.22, pp.2767-2781, 2013. ,
DOI : 10.1083/jcb.200212033
Role of the Microenvironment in Ovarian Cancer Stem Cell Maintenance, BioMed Research International, vol.2, issue.5, p.630782, 2013. ,
DOI : 10.1007/s10585-009-9242-2
Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin, Cancer Letters, vol.288, issue.1, pp.50-56, 2010. ,
DOI : 10.1016/j.canlet.2009.06.023
The Interleukin-8 Pathway in Cancer, Clinical Cancer Research, vol.14, issue.21, pp.6735-6741, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-4843
THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST., The Lancet, vol.133, issue.3421, pp.98-101 ,
DOI : 10.1016/S0140-6736(00)49915-0
Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts, Cancer Res, vol.44, pp.3584-3592, 1984. ,
Preparing the "Soil": The Premetastatic Niche, Cancer Research, vol.66, issue.23, pp.11089-11093, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-2407
The metastatic niche: adapting the foreign soil, Nature Reviews Cancer, vol.3, issue.4, pp.285-293, 2009. ,
DOI : 10.1038/nrc2621
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche, Cancer Cell, vol.15, issue.1, pp.35-44, 2009. ,
DOI : 10.1016/j.ccr.2008.11.012
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin, Journal of Clinical Investigation, vol.118, issue.4, pp.1367-1379, 2008. ,
DOI : 10.1172/JCI33775
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma, Cell, vol.154, issue.5, pp.1060-1073, 2013. ,
DOI : 10.1016/j.cell.2013.07.036
Extra-abdominal Metastases From Epithelial Ovarian Carcinoma, International Journal of Gynecological Cancer, vol.22, issue.4, pp.611-614, 2009. ,
DOI : 10.1111/IGC.0b013e3181a416d0
Distant metastases in ovarian carcinoma, International Journal of Gynecological Cancer, vol.13, issue.2, pp.125-129, 2003. ,
DOI : 10.1046/j.1525-1438.2003.13054.x
Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression, Clinical & Experimental Metastasis, vol.89, issue.12, pp.643-655, 2008. ,
DOI : 10.1007/s10585-008-9171-5
Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells, International Journal of Cancer, vol.50, issue.3, pp.393-399, 1994. ,
DOI : 10.1002/ijc.2910580315
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment, Cancer Research, vol.71, issue.24, pp.7463-7470, 2011. ,
DOI : 10.1158/0008-5472.CAN-11-2449
Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity, Cancer Res, vol.53, pp.5028-5032, 1993. ,
Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer, Cytokine, vol.42, issue.1, pp.77-84, 2008. ,
DOI : 10.1016/j.cyto.2008.01.011
Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1785, issue.2, pp.232-265, 2008. ,
DOI : 10.1016/j.bbcan.2008.01.001
Microscopic Benign and Invasive Malignant Neoplasms and a Cancer-Prone Phenotype in Prophylactic Oophorectomies, JNCI Journal of the National Cancer Institute, vol.88, issue.24, pp.1810-1820, 1996. ,
DOI : 10.1093/jnci/88.24.1810
Ovarian Epithelial Dysplasia and Prophylactic Oophorectomy for Genetic Risk, International Journal of Gynecological Cancer, vol.5, issue.1 ,
DOI : 10.1111/IGC.0b013e3181990127
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms, Cancer Biology & Therapy, vol.5, issue.7, pp.779-785, 2006. ,
DOI : 10.4161/cbt.5.7.2751
Peritoneal inflammation -A microenvironment for Epithelial Ovarian Cancer (EOC), Journal of Translational Medicine, vol.2, issue.1, p.23, 2004. ,
DOI : 10.1186/1479-5876-2-23
Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours, PLoS ONE, vol.171, issue.2, p.3894, 2008. ,
DOI : 10.1371/journal.pone.0003894.s002
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages, Cancer Letters, vol.326, issue.1, pp.59-68, 2012. ,
DOI : 10.1016/j.canlet.2012.07.020
Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation, Cell Death and Disease, vol.126, issue.10, p.887, 2013. ,
DOI : 10.1002/pmic.200700231
Cancer Statistics, 2008, Cancer statistics, pp.71-96, 2008. ,
DOI : 10.3322/CA.2007.0010
Effects of histamine and its receptor antagonists on peritoneal permeability, Kidney International, vol.34, issue.6, pp.786-790, 1988. ,
DOI : 10.1038/ki.1988.250
Role of mesothelial cells in peritoneal antibacterial defence., Journal of Clinical Pathology, vol.44, issue.7, pp.600-604, 1991. ,
DOI : 10.1136/jcp.44.7.600
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum, International Journal of Cancer, vol.92, issue.7, pp.1463-1472, 2007. ,
DOI : 10.1002/ijc.22874
Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion, Clinical & Experimental Metastasis, vol.13, issue.5, pp.373-380, 1995. ,
DOI : 10.1007/BF00121913
The First Line of Intra-abdominal Metastatic Attack: Breaching the Mesothelial Cell Layer, Cancer Discovery, vol.1, issue.2, pp.100-102, 2011. ,
DOI : 10.1158/2159-8290.CD-11-0117
Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources, Journal of the Society for Gynecologic Investigation, vol.6, issue.6, pp.333-340, 1999. ,
DOI : 10.1016/S1071-5576(99)00040-4
Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer, Clin Cancer Res, vol.11, pp.113-122, 2005. ,
Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis, Journal of Surgical Research, vol.115, issue.1, pp.113-120, 2003. ,
DOI : 10.1016/S0022-4804(03)00307-X
??1-Integrins Regulate the Formation and Adhesion of Ovarian Carcinoma Multicellular Spheroids, The American Journal of Pathology, vol.159, issue.6, pp.2071-2080, 2001. ,
DOI : 10.1016/S0002-9440(10)63058-1
Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis, Cancer Letters, vol.91, issue.2, pp.229-234, 1995. ,
DOI : 10.1016/0304-3835(95)03743-G
Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium, Cancer Discovery, vol.1, issue.2, pp.144-147, 2011. ,
DOI : 10.1158/2159-8274.CD-11-0010
Omental Adipose Tissue-Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors, Clinical Cancer Research, vol.18, issue.3, pp.771-782, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-1916
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis, Journal of Clinical Oncology, vol.20, issue.5, pp.1248-1259, 2002. ,
DOI : 10.1200/JCO.2002.20.5.1248
Chemotherapy in epithelial ovarian cancer, Cancer Letters, vol.303, issue.2, pp.73-83, 2011. ,
DOI : 10.1016/j.canlet.2011.01.026
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial, The Lancet, vol.376, issue.9737, pp.376245-251, 2010. ,
DOI : 10.1016/S0140-6736(10)60893-8
Management of Platinum-Sensitive Recurrent Ovarian Cancer, Seminars in Oncology, vol.33, pp.12-16, 2006. ,
DOI : 10.1053/j.seminoncol.2006.03.012
Environment-mediated drug resistance: a major contributor to minimal residual disease, Nature Reviews Cancer, vol.112, issue.9, pp.665-674, 2009. ,
DOI : 10.1038/nrc2714
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo, Science, vol.247, issue.4949, pp.1457-1461, 1990. ,
DOI : 10.1126/science.2108497
Different Modalities of Intercellular Membrane Exchanges Mediate Cell-to-cell P-glycoprotein Transfers in MCF-7 Breast Cancer Cells, Journal of Biological Chemistry, vol.287, issue.10, pp.7374-7387, 2012. ,
DOI : 10.1074/jbc.M111.312157
URL : https://hal.archives-ouvertes.fr/hal-00993031
Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells, Proceedings of the National Academy of Sciences, vol.102, issue.6, pp.1933-1938, 2005. ,
DOI : 10.1073/pnas.0401851102
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results, Journal of Cancer Research and Clinical Oncology, vol.28, issue.5, pp.1637-1645, 2009. ,
DOI : 10.1007/s00432-009-0667-4
Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study, European Journal of Surgical Oncology (EJSO), vol.36, issue.6, pp.589-593, 2010. ,
DOI : 10.1016/j.ejso.2010.04.005
URL : https://hal.archives-ouvertes.fr/hal-00599226